斯洛文尼亚的肾脏替代疗法：2013年数据摘录

Renal Replacement Therapy in Slovenia: Excerpts From 2013 Data.

作者信息

Buturović-Ponikvar Jadranka, Gubenšek Jakob, Arnol Miha, Adamlje Tone, Ceglar Zlata, Damevska Gabriela, Globokar Mateja, Černe Senka, Čufer Andrej, Drozg Andrej, Ekart Robert, Knap Bojan, Kandus Aljoša, Kapun Sonja, Kralj-Lopert Simona, Klančič Dimitrij, Kunc-Rešek Natalija, Kralj Stojan, Malovrh Marko, Močivnik Marjan, Novljan Gregor, Romozi Karmen, Rus Igor, Saksida Silvan, Vujkovac Bojan, Ponikvar Rafael

机构信息

Department of Nephrology, University Medical Centre Ljubljana, Ljubljana.

Dialysis Center, General Hospital Trbovlje, Trbovlje.

出版信息

Ther Apher Dial. 2016 Jun;20(3):223-8. doi: 10.1111/1744-9987.12427.

DOI:10.1111/1744-9987.12427

PMID:27312905

Abstract

This report provides a summary of the 2013 Slovenian renal replacement therapy (RRT) data, obtained from 24 renal centers: 23 dialysis and one transplant center, referring from 31 December 2013, with 100% response rate to individual patient questionnaires. Slovenia had a population of 2 061 085 on 1 January 2014. The total number of patients treated by RRT was 2077, i.e. 1008.3 per million of population (pmp); 1349 (65%) were treated by hemodialysis, 52 (2.5%) by peritoneal dialysis, and 676 (32.5%) had a functioning kidney graft. A total of 260 incident patients, 126.2 pmp (at day one), started RRT, their median age was 69 years, 59.8% were men,. 58.5% of hemodialysis patients were treated with on-line hemodiafiltration. Vascular access was arteriovenous fistula in 79%, polytetrafluoroethylene graft in 8%, and catheter in 13% of patients, mean blood flow 276 ± 41 mL/min, 5.5% dialyzed in a single-needle mode. The crude death rate was 11.4% in all RRT patients (incident patients day 1 included, 15.9% in hemodialysis, 12.3% in peritoneal dialysis, 2.1% in transplant recipients). 60 kidney transplantations were performed in 2013, from deceased donors.

摘要

本报告总结了2013年斯洛文尼亚肾脏替代治疗（RRT）数据，这些数据来自24个肾脏中心：23个透析中心和1个移植中心，数据截止于2013年12月31日，对个体患者问卷的回复率为100%。2014年1月1日，斯洛文尼亚人口为2061085人。接受RRT治疗的患者总数为2077人，即每百万人口中有1008.3人（pmp）；1349人（65%）接受血液透析治疗，52人（2.5%）接受腹膜透析治疗，676人（32.5%）拥有功能正常的肾移植。共有260名新发病例患者开始接受RRT治疗（第一天时为126.2 pmp），他们的中位年龄为69岁，男性占59.8%。58.5%的血液透析患者接受在线血液透析滤过治疗。79%的患者血管通路为动静脉内瘘，8%为聚四氟乙烯移植物，13%为导管，平均血流量为276±41 mL/min，5.5%的患者采用单针模式进行透析。所有RRT患者的粗死亡率为11.4%（包括第一天的新发病例患者，血液透析患者中为15.9%，腹膜透析患者中为12.3%，移植受者中为2.1%）。2013年进行了60例来自已故供体的肾移植手术。